Caspase-14-Deficient Mice Are More Prone to the Development of Parakeratosis  Esther Hoste, Geertrui Denecker, Barbara Gilbert, Filip Van Nieuwerburgh,

Slides:



Advertisements
Similar presentations
Keratin 9 Is Required for the Structural Integrity and Terminal Differentiation of the Palmoplantar Epidermis  Dun Jack Fu, Calum Thomson, Declan P. Lunny,
Advertisements

Cyclic Alopecia and Abnormal Epidermal Cornification in Zdhhc13-Deficient Mice Reveal the Importance of Palmitoylation in Hair and Skin Differentiation 
Low Humidity Stimulates Epidermal DNA Synthesis and Amplifies the Hyperproliferative Response to Barrier Disruption: Implication for Seasonal Exacerbations.
Transglutaminase 3 Protects against Photodamage
Growth Retardation, Loss of Desmosomal Adhesion, and Impaired Tight Junction Function Identify a Unique Role of Plakophilin 1 In Vivo  Katrin Rietscher,
SERPINB3/B4 Contributes to Early Inflammation and Barrier Dysfunction in an Experimental Murine Model of Atopic Dermatitis  Umasundari Sivaprasad, Kayla.
An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling  Khalifa El Malki,
A Topical Mitochondria-Targeted Redox-Cycling Nitroxide Mitigates Oxidative Stress- Induced Skin Damage  Rhonda M. Brand, Michael W. Epperly, J. Mark Stottlemyer,
Negative Electric Potential Induces Alteration of Ion Gradient and Lamellar Body Secretion in the Epidermis, and Accelerates Skin Barrier Recovery After.
Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1  Katelynn A. Milora, Hangfei Fu, Ornella Dubaz,
An Alternatively Spliced IL-15 Isoform Modulates Abrasion-Induced Keratinocyte Activation  Tsung-Lin Lee, Mei-Ling Chang, Yu-Jei Lin, Ming-Hsun Tsai,
TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus  Jessica L. Doerner, Jing Wen, Yumin.
Upregulation of Inflammatory Cytokines and Oncogenic Signal Pathways Preceding Tumor Formation in a Murine Model of T-Cell Lymphoma in Skin  Xuesong Wu,
Type I IL-1 Receptor Mediates IL-1 and Intracellular IL-1 Receptor Antagonist Effects in Skin Inflammation  Gaby Palmer, Dominique Talabot-Ayer, Gürkan.
Inhibition of UVB-Induced Skin Tumor Development by Drinking Green Tea Polyphenols Is Mediated Through DNA Repair and Subsequent Inhibition of Inflammation 
Reduced Inflammatory Threshold Indicates Skin Barrier Defect in Transglutaminase 3 Knockout Mice  Peter Bognar, Ilona Nemeth, Balazs Mayer, Dora Haluszka,
Trim32 Deficiency Enhances Th2 Immunity and Predisposes to Features of Atopic Dermatitis  Yuangang Liu, Zhiping Wang, Rachel De La Torre, Ashley Barling,
Decreased Expression of Caveolin-1 Contributes to the Pathogenesis of Psoriasiform Dermatitis in Mice  Yukie Yamaguchi, Yuko Watanabe, Tomoya Watanabe,
Yasuyo Sano, Jin Mo Park  Journal of Investigative Dermatology 
Deficiency of PPARβ/δ in the Epidermis Results in Defective Cutaneous Permeability Barrier Homeostasis and Increased Inflammation  Mao-Qiang Man, Grant.
Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2  Kave Shams, Gillian J. Wilson, Mark Singh,
Jason E. Hawkes, Johann E. Gudjonsson, Nicole L. Ward 
Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition.
Transglutaminase 3 Protects against Photodamage
IL-27 Activates Th1-Mediated Responses in Imiquimod-Induced Psoriasis-Like Skin Lesions  Sayaka Shibata, Yayoi Tada, Yoshihide Asano, Koichi Yanaba, Makoto.
Christina A. Young, Richard L
Calcium Ion Gradients and Dynamics in Cultured Skin Slices of Rat Hindpaw in Response to Stimulation with ATP  Moe Tsutsumi, Sumiko Denda, Kaori Inoue,
IL-1R1 Signaling Facilitates Munro’s Microabscess Formation in Psoriasiform Imiquimod-Induced Skin Inflammation  Mireia Uribe-Herranz, Li-Hua Lian, Kirsten.
In Vivo Induction of Cutaneous Inflammation Results in the Accumulation of Extracellular Trap-Forming Neutrophils Expressing RORγt and IL-17  Romy R.M.C.
An Alternatively Spliced IL-15 Isoform Modulates Abrasion-Induced Keratinocyte Activation  Tsung-Lin Lee, Mei-Ling Chang, Yu-Jei Lin, Ming-Hsun Tsai,
Vitamin D Receptor and Coactivators SRC2 and 3 Regulate Epidermis-Specific Sphingolipid Production and Permeability Barrier Formation  Yuko Oda, Yoshikazu.
Essential Role of the Keratinocyte-Specific Endonuclease DNase1L2 in the Removal of Nuclear DNA from Hair and Nails  Heinz Fischer, Sandra Szabo, Jennifer.
Integrin β6-Deficient Mice Show Enhanced Keratinocyte Proliferation and Retarded Hair Follicle Regression after Depilation  Yanshuang Xie, Kevin J. McElwee,
Development of Atopic Dermatitis in Mice Transgenic for Human Apolipoprotein C1  Lex Nagelkerken, Perry Verzaal, Tonny Lagerweij, Carla Persoon-Deen, Jimmy.
Mohammad Rashel, Ninche Alston, Soosan Ghazizadeh 
Unsaturated Fatty Acids Induce Calcium Influx into Keratinocytes and Cause Abnormal Differentiation of Epidermis  Yuji Katsuta, Toshii Iida, Shinji Inomata,
Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis  Michael Devos, Denis A. Mogilenko,
Epidermal RelA Specifically Restricts Contact Allergen–Induced Inflammation and Apoptosis in Skin  Snehlata Kumari, Benjamin Herzberg, Ruth Pofahl, Thomas.
Enrique C. Torchia, Lei Zhang, Aaron J. Huebner, Subrata Sen, Dennis R
Establishment of Two Mouse Models for CEDNIK Syndrome Reveals the Pivotal Role of SNAP29 in Epidermal Differentiation  Stina A. Schiller, Christina Seebode,
Clemens Esche, Vladimir M
Stimulation of PPARα Promotes Epidermal Keratinocyte Differentiation In Vivo  László G. Kömüves, Karen Hanley, Anne-Marie Lefebvre, Mao-Qiang Man, Dean.
Histamine H1 and H2 Receptor Antagonists Accelerate Skin Barrier Repair and Prevent Epidermal Hyperplasia Induced by Barrier Disruption in a Dry Environment 
Anne T. Funding, Claus Johansen, Matthias Gaestel, Bo M
Short-Term Glucocorticoid Treatment Compromises Both Permeability Barrier Homeostasis and Stratum Corneum Integrity: Inhibition of Epidermal Lipid Synthesis.
Elevated Dietary Magnesium Prevents Connective Tissue Mineralization in a Mouse Model of Pseudoxanthoma Elasticum (Abcc6−/−)  Jennifer LaRusso, Qiaoli.
Topical Peroxisome Proliferator Activated Receptor Activators Accelerate Postnatal Stratum Corneum Acidification  Joachim W. Fluhr, Mao-Qiang Man, Jean-Pierre.
Exposure to a Dry Environment Enhances Epidermal Permeability Barrier Function  Mitsuhiro Denda, Junko Sato, Yoshiko Masuda, Toru Tsuchiya, Junichi Koyama,
The “Caveolae Brake Hypothesis” and the Epidermal Barrier
Increased Sensitivity of Histidinemic Mice to UVB Radiation Suggests a Crucial Role of Endogenous Urocanic Acid in Photoprotection  Caterina Barresi,
Modulation of Hair Growth with Small Molecule Agonists of the Hedgehog Signaling Pathway  Rudolph D. Paladini, Jacqueline Saleh, Changgeng Qian, Guang-Xin.
The Vitamin D Receptor Is Required for Mouse Hair Cycle Progression but not for Maintenance of the Epidermal Stem Cell Compartment  Héctor G. Pálmer,
Localization of Serine Racemase and Its Role in the Skin
Wound Healing Is Defective in Mice Lacking Tetraspanin CD151
Increased Severity of Bleomycin-Induced Skin Fibrosis in Mice with Leukocyte-Specific Protein 1 Deficiency  JianFei Wang, Haiyan Jiao, Tara L. Stewart,
Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition.
How Effective Is Tacrolimus in the Imiquimod-Induced Mouse Model of Psoriasis?  Hannah Pischon, Moritz Radbruch, Anja Ostrowski, Fabian Schumacher, Stefan.
Epidermal Inactivation of the Glucocorticoid Receptor Triggers Skin Barrier Defects and Cutaneous Inflammation  Lisa M. Sevilla, Víctor Latorre, Ana Sanchis,
Yuji Owada, Ichiro Suzuki, Ryoji Suzuki, Hisatake Kondo 
Syed M. Meeran, Thejass Punathil, Santosh K. Katiyar 
Normal Wound Healing in Mice Deficient for Fibulin-5, an Elastin Binding Protein Essential for Dermal Elastic Fiber Assembly  Qian Zheng, Jiwon Choi,
Novel Anti-Inflammatory Properties of the Angiogenesis Inhibitor Vasostatin  Rainer Huegel, Paula Velasco, Maria De La Luz Sierra, Enno Christophers, Jens.
Ingenol Mebutate Field-Directed Treatment of UVB-Damaged Skin Reduces Lesion Formation and Removes Mutant p53 Patches  Sarah-Jane Cozzi, Steven M. Ogbourne,
Juan A. Pena, Jacqueline L. Losi-Sasaki, Jennifer L. Gooch 
C/EBPα Expression Is Downregulated in Human Nonmelanoma Skin Cancers and Inactivation of C/EBPα Confers Susceptibility to UVB-Induced Skin Squamous Cell.
Eric N. Johnson  Journal of Investigative Dermatology 
Filaggrin Degradation by Caspase-14 Is Required for UVB Photoprotection but Does Not Influence Allergic Sensitization in a Mouse Model of Atopic Dermatitis 
Systemic PPARγ Ligation Inhibits Allergic Immune Response in the Skin
Journal of Investigative Dermatology
Hyaluronan–CD44 Interaction Stimulates Keratinocyte Differentiation, Lamellar Body Formation/Secretion, and Permeability Barrier Homeostasis  Lilly Y.W.
Presentation transcript:

Caspase-14-Deficient Mice Are More Prone to the Development of Parakeratosis  Esther Hoste, Geertrui Denecker, Barbara Gilbert, Filip Van Nieuwerburgh, Leslie van der Fits, Bob Asselbergh, Riet De Rycke, Jean- Pierre Hachem, Dieter Deforce, Errol P. Prens, Peter Vandenabeele, Wim Declercq  Journal of Investigative Dermatology  Volume 133, Issue 3, Pages 742-750 (March 2013) DOI: 10.1038/jid.2012.350 Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Cornification defects in caspase-14−/−newborns and adults. Skin sections of caspase-14+/+ and caspase-14−/− mice at P3.5 days and at the age of 9 weeks were examined by electron microscopy for stratum corneum (SC) abnormalities. (a) General view of the transitional and cornifying layers in wild-type (WT) and caspase-14−/− skin. Upper panels, bar=2μm; lower panels, bar=1μm. (b) Detailed view on the SC1 layer in WT and caspase-14−/− skin at P3.5 days. Arrowheads indicate the cornified envelope. SG, stratum granulosum; SCx, xth layer of cornified cells. Bar=500nm. Journal of Investigative Dermatology 2013 133, 742-750DOI: (10.1038/jid.2012.350) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Caspase-14−/− mice develop more and larger parakeratotic plaques upon acetone-induced barrier disruption. (a) Hematoxylin and eosin (H&E)-stained skin sections of wild-tpe (WT) and caspase-14−/− back skin that was left untreated or subjected to repetitive treatment two times daily with saline or acetone wipes for 5 days. Acetone treatment results in parakeratotic plaque formation in WT and caspase-14−/− mice. A representative image of saline (NaCl)- and acetone-treated skin is shown for both genotypes. Bar=200μm. (b) Transepidermal water loss (TEWL) measurements were recorded 24hours after the last treatment. Values of the two genotypes were compared using two-way analysis of variance (ANOVA) testing with Bonferroni post-tests; P-values are indicated with * (<0.05). (c) Parakeratosis was quantified in all experimental groups on H&E-stained skin sections. Values depicted in the graph are the % of parakeratotic stratum corneum (SC) surface. These data were statistically analyzed by a logistic regression model as explained in Materials and Methods. Bars represent mean values±SEM. WT untreated: n=10; knockout (KO) untreated: n=10; WT NaCl: n=10; KO NaCl: n=10; WT acetone: n=16; KO acetone: n=16. The total length of skin analyzed was 107.75mm in WT untreated; 95.25mm in KO untreated; 78.5mm in WT NaCl; 111mm in KO NaCl; 252.25mm in WT acetone; and 351.75mm in KO acetone. (d) Mice treated as in c were analyzed for the number of parakeratotic plaques larger than 100μm over a total section length of 10cm. Only statistically significant differences are indicated by asterisks (b and c). Journal of Investigative Dermatology 2013 133, 742-750DOI: (10.1038/jid.2012.350) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 Caspase-14−/− mice are more sensitive to vehicle- and imiquimod (IMQ)-induced epidermal scaling than wild-type (WT) mice. Scaling of the epidermis was scored independently by two researchers on a scale from 0 to 4: 0, none; 1, slight; 2, moderate; 3, marked; and 4, very marked. WT untreated: n=4; knockout (KO) untreated: n=4; WT vehicle: n=6; KO vehicle: n=6; WT IMQ: n=11; and KO IMQ: n=12. All values from both genotypes were compared using two-way analysis of variance (ANOVA) testing with Bonferroni post-tests. Bars represent mean values±SEM. P-values are indicated with *** (<0.001). Only statistically significant differences are indicated by asterisks. Journal of Investigative Dermatology 2013 133, 742-750DOI: (10.1038/jid.2012.350) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 4 Caspase-14−/− mice are more prone to the development of parakeratosis than their wild-type (WT) counterparts upon topical imiquimod (IMQ) treatment. (a) Hematoxylin and eosin (H&E) staining of back skin of caspase-14+/+ and caspase-14−/− mice left untreated, treated with vehicle cream, or treated with IMQ-containing cream for 8 consecutive days, after which they were killed and samples obtained. A representative image is shown for each condition. Bar=20μm. (b) Parakeratosis was quantified in all experimental groups on H&E-stained skin sections. Values depicted in the graph represent the percentage of parakeratotic stratum corneum (SC) out of the total SC. These data were statistically analyzed by a logistic regression model as explained in Materials and Methods. Three sections per mouse sample were analyzed. WT untreated: n=8; knockout (KO) untreated: n=8; WT vehicle: n=11; KO vehicle: n=11; WT IMQ: n=20; and KO IMQ: n=21 (c) Epidermal thickness was measured using the ImageJ software—four measurements were performed on each H&E-stained image; three images per mouse were analyzed. The thickness of the epidermis was determined by measuring the distance from the basement membrane to the upper granular layer, excluding the cornified layers. All values from the two genotypes were compared using two-way analysis of variance (ANOVA) testing with Bonferroni post-tests. Bars represent mean values±SEM. P-values are indicated with * (<0.05) or *** (<0.001). (b and c) Only statistically significant differences are indicated by asterisks. Journal of Investigative Dermatology 2013 133, 742-750DOI: (10.1038/jid.2012.350) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 5 Imiquimod (IMQ)-treated wild-type (WT) and caspase-14−/− skin have similar numbers of infiltrating leukocytes. (a) Back skin sections of untreated, vehicle-treated, and IMQ-treated caspase-14+/+ and caspase-14−/− mice were probed with anti-CD45 antibody. A representative image is shown for each condition. Bar=40μm. (b) Quantification of diaminobenzidine (DAB) positivity in stained skin sections is represented as DAB-positive area as a percent of total area (epidermis and dermis). Three sections per mouse sample were analyzed. WT untreated: n=12; knockout (KO) untreated: n=12; WT vehicle: n=18; KO vehicle: n=18; WT IMQ: n=31; and KO IMQ: n=34. Values of the two genotypes were compared using a logistic regression model as explained in Materials and Methods. Bars represent mean values±SEM. We could not observe statistically significant differences between the two genotypes. Journal of Investigative Dermatology 2013 133, 742-750DOI: (10.1038/jid.2012.350) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 6 Barrier disruption induced by imiquimod (IMQ) treatment is more pronounced in caspase-14−/− mice relative to controls. Transepidermal water loss (TEWL) measurements were recorded on caspase-14+/+ and caspase-14−/− shaved back skin on days 0, 4, 6, and 8 of treatment. Bars represent mean values±SD. Wild-type (WT) untreated: n=4; knockout (KO) untreated: n=4; WT vehicle: n=6; KO vehicle: n=6; WT IMQ: n=11; and KO IMQ: n=12. Values of the two genotypes were compared using two-way analysis of variance (ANOVA) testing with Bonferroni post-tests; P-values are indicated with * (<0.05), ** (0.05–0.001), or *** (<0.001). Only statistically significant differences are indicated by asterisks. Journal of Investigative Dermatology 2013 133, 742-750DOI: (10.1038/jid.2012.350) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions